eculizumab 300 MG per 30 ML Injection

RxCUI
700384
RxNorm name
eculizumab 300 MG per 30 ML Injection
Display name
eculizumab 300 MG per 30 ML Injection
Full name
eculizumab 300 MG per 30 ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:26

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125166Soliriseculizumab351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SOLIRISECULIZUMABAlexion Pharmaceuticals Inc.ebcd67fa-b4d1-4a22-b33d-ee8bf6b9c7222026-07-08Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 700384

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
ebcd67fa-b4d1-4a22-b33d-ee8bf6b9c722eculizumab 300 MG per 30 ML InjectionSY42These highlights do not include all the information needed to use SOLIRIS safely and effectively. See full prescribing information for SOLIRIS. SOLIRIS ® (eculizumab) injection, for intravenous use Initial U.S. Approval: 200720250307
ebcd67fa-b4d1-4a22-b33d-ee8bf6b9c72230 ML eculizumab 10 MG/ML InjectionSCD42These highlights do not include all the information needed to use SOLIRIS safely and effectively. See full prescribing information for SOLIRIS. SOLIRIS ® (eculizumab) injection, for intravenous use Initial U.S. Approval: 200720250307
ebcd67fa-b4d1-4a22-b33d-ee8bf6b9c722eculizumab 300 MG in 30 ML InjectionPSN42These highlights do not include all the information needed to use SOLIRIS safely and effectively. See full prescribing information for SOLIRIS. SOLIRIS ® (eculizumab) injection, for intravenous use Initial U.S. Approval: 200720250307